Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug Ruby Khatun Khatun10 Nov 2017 4:24 PM ISTNew Delhi: The Central Drug Standards Control Organization (CDSCO) has initiated an inquiry against the two domestic drug makers Zydus Cadila and...
Granules India posts Q2 net profit at Rs 40 crore Ruby Khatun Khatun10 Nov 2017 10:47 AM ISTNew Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
Piramal group expands healthcare project ASARA Ruby Khatun Khatun10 Nov 2017 10:31 AM ISTVishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...
Novartis takes fight to Pfizers Ibrance with new Kisqali data Ruby Khatun Khatun10 Nov 2017 10:17 AM ISTZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
Thousands of drugs at risk if no Brexit deal, companies warn Ruby Khatun Khatun10 Nov 2017 9:30 AM ISTSupplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical...
MORE DRUGS added to the Schedule H list Ruby Khatun Khatun9 Nov 2017 11:38 AM ISTThrough a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 10:32 AM ISTNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 10:16 AM ISTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
US senators press Allergan for details on patent deal with tribe Ruby Khatun Khatun9 Nov 2017 9:15 AM ISTA group of U.S. senators on Tuesday asked drugmaker Allergan Plc to produce documents relating to its agreement to transfer patents to a Native...
Cipla shares tank over 7 percent, mcap falls by Rs 3,785.5 crore Ruby Khatun Khatun8 Nov 2017 10:21 AM ISTNew Delhi: Shares of Cipla slumped over 7 percent even as the company reported a consolidated net profit of Rs 434.95 crore for the second quarter...
